Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies
The studies offer perhaps the most concrete rebuttal yet to an idea that GLP-1 drugs, which have profound benefits on weight loss and heart health, might also help comb...